Chengdu Kanghong Pharmaceutical Group Co., Ltd (002773.SZ)
CNY 19.72
(0.15%)
CNY 19.72
(0.15%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 3.95 Billion | 3.38 Billion | 3.6 Billion | 3.29 Billion | 3.25 Billion | 2.91 Billion |
| Cost of Revenue | 438.4 Million | 388.03 Million | 354.6 Million | 329.73 Million | 263.84 Million | 228.5 Million |
| Gross Profit | 3.51 Billion | 3 Billion | 3.25 Billion | 2.96 Billion | 2.99 Billion | 2.68 Billion |
| Operating Expenses | 2.25 Billion | 2.06 Billion | 2.74 Billion | 3.53 Billion | 2.22 Billion | 1.96 Billion |
| Selling, General and Administrative Expenses | 1.94 Billion | 1.46 Billion | 1.56 Billion | 1.69 Billion | 1.78 Billion | 1.6 Billion |
| Research and Development Expenses | 442.48 Million | 373.99 Million | 1 Billion | 1.67 Billion | 286.94 Million | 230.36 Million |
| Other Expenses | -128.22 Million | 221.25 Million | 168.96 Million | 166.93 Million | 157.51 Million | 3.25 Million |
| Cost and Expenses | 2.69 Billion | 2.45 Billion | 3.09 Billion | 3.86 Billion | 2.48 Billion | 2.19 Billion |
| Operating Income | 1.26 Billion | 1.01 Billion | 606.69 Million | -574.09 Million | 820.75 Million | 796.2 Million |
| Interest Expense | 150.77 Thousand | 229.43 Thousand | 915.18 Thousand | 502.13 Thousand | 572.79 Thousand | 46.03 Million |
| Income Tax Expense | 202.79 Million | 164.48 Million | -27.66 Million | -249.65 Million | 116.98 Million | 104.51 Million |
| Earnings before Tax | 1.23 Billion | 1.03 Billion | 393.42 Million | -519.51 Million | 835.17 Million | 799.45 Million |
| Net Income | 1.04 Billion | 896.67 Million | 421.08 Million | -269.85 Million | 718.19 Million | 694.94 Million |
| Earnings Per Share Basic | 1.14 | 0.98 | 0.46 | -0.29 | 0.82 | 0.80 |
| Earnings Per Share Diluted | 1.14 | 0.98 | 0.46 | -0.29 | 0.82 | 0.80 |
| Weighted Average Shares Outstanding | 916.46 Million | 919.46 Million | 919.46 Million | 919.46 Million | 873.49 Million | 868.67 Million |
| Weighted Average Shares Outstanding (Diluted) | 916.46 Million | 919.46 Million | 919.46 Million | 919.46 Million | 873.49 Million | 868.67 Million |
| Gross Margin | 0.89 | 0.89 | 0.90 | 0.90 | 0.92 | 0.92 |
| EBIT Margin | 0.35 | 0.32 | 0.21 | -0.12 | 0.27 | 0.28 |
| Profit Margin | 0.26 | 0.26 | 0.12 | -0.08 | 0.22 | 0.24 |
| EBITDA | 1.38 Billion | 1.09 Billion | 545.89 Million | -396.42 Million | 932.08 Million | 881.57 Million |
| Earnings Before Tax Margin | 0.32 | 0.30 | 0.17 | -0.17 | 0.25 | 0.27 |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 |
|---|---|---|---|---|---|---|
| Revenue | 1.11 Billion | 1.18 Billion | 1.09 Billion | 958.64 Million | 3.95 Billion | 1.07 Billion |
| Cost of Revenue | 111.23 Million | 150.86 Million | 114.85 Million | 111.98 Million | 438.4 Million | 111.53 Million |
| Gross Profit | 1 Billion | 1.03 Billion | 977.92 Million | 846.66 Million | 3.51 Billion | 966.87 Million |
| Operating Expenses | 693.46 Million | 703.67 Million | 547.54 Million | 615.9 Million | 2.35 Billion | 619.31 Million |
| Selling, General and Administrative Expenses | 948.16 Million | 585.78 Million | 483.2 Million | 155.29 Million | - | 669.53 Million |
| Research and Development Expenses | 149.28 Million | 117.14 Million | 63.84 Million | 163.32 Million | - | 88.24 Million |
| Other Expenses | -403.98 Million | -746.31 Thousand | -556.56 Thousand | -14.81 Million | -27.98 Million | -3.69 Million |
| Cost and Expenses | 804.69 Million | 854.54 Million | 662.4 Million | 727.88 Million | 2.79 Billion | 730.84 Million |
| Operating Income | 328.19 Million | 329.07 Million | 446.53 Million | 265.69 Million | 1.26 Billion | 364.81 Million |
| Interest Expense | - | - | - | - | - | - |
| Income Tax Expense | 42.51 Million | 56.25 Million | 74.5 Million | 36.79 Million | 202.79 Million | 64.62 Million |
| Earnings before Tax | 320.87 Million | 371.36 Million | 445.98 Million | 251.71 Million | 1.23 Billion | 361.12 Million |
| Net Income | 281.49 Million | 318.69 Million | 373.52 Million | 219.4 Million | 1.04 Billion | 300.02 Million |
| Earnings Per Share Basic | 0.31 | 0.35 | 0.41 | 0.24 | - | 0.33 |
| Earnings Per Share Diluted | 0.31 | 0.35 | 0.41 | 0.24 | - | 0.33 |
| Weighted Average Shares Outstanding | 919.77 Million | 919.75 Million | 911.02 Million | 919.46 Million | 916.46 Million | 919.46 Million |
| Weighted Average Shares Outstanding (Diluted) | 919.77 Million | 919.75 Million | 911.02 Million | 919.46 Million | 916.46 Million | 919.46 Million |
| Gross Margin | 0.90 | 0.87 | 0.89 | 0.88 | 0.89 | 0.90 |
| EBIT Margin | 0.28 | 0.33 | 0.39 | 0.24 | - | 0.32 |
| Profit Margin | 0.25 | 0.27 | 0.34 | 0.23 | 0.26 | 0.28 |
| EBITDA | 312.46 Million | 387.18 Million | 430.46 Million | 231.11 Million | - | 347.88 Million |
| Earnings Before Tax Margin | 0.29 | 0.28 | 0.41 | 0.28 | 0.32 | 0.34 |
NERD
1030
NNGPF
006800
GTE
AURIONPRO